Article Information
History
- July 22, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Lana M Chahine1,*,
- David-Erick Lafontant2,
- Seung Ho Choi2,
- Hirotaka Iwaki3,4,5,
- Cornelis Blauwendraat4,5,
- Andrew B Singleton4,5,6,
- Michael C Brumm2,
- Roy N. Alcalay7,
- Kalpana Merchant8,
- Kelly Nicole Holohan Nudelman9,
- Alain Dagher10,
- Andrew Vo10,
- Qin Tao10,
- Charles S Venuto11,
- Karl Kieburtz11,
- Kathleen L Poston12,
- Susan Bressman13,
- Paulina Gonzalez-Latapi8,
- Brian Avants14,
- Christopher Coffey2,
- Danna Jennings15,
- Eduard Tolosa16,
- Andrew Siderowf17,
- Ken Marek18,
- Tanya Simuni8 and
- Parkinson’s Progression Markers Initiative
- 1Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA, 15213
- 2Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA
- 3DataTecnica LLC, Washington, District of Columbia, USA. (2) Center for Alzheimer’s and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
- 4Center for Alzheimer’s and Related Dementias, National Institute on Aging and Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
- 5Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
- 6National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
- 7Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel and Department of Neurology; Columbia University Irving Medical Center.
- 8Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- 9Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA
- 10Montreal Neurological Institute, McGill University, Montreal, Canada
- 11Department of Neurology, Center for Health and Technology, University of Rochester Medical Center, Rochester, NY
- 12Department of Neurology, Stanford University School of Medicine, Palo Alto, CA, USA
- 13Department of Neurology, Mount Sinai Beth Israel and Icahn School of Medicine, Mount Sinai, New York City, New York, USA
- 14Invicro, LLC, Needham, MA, USA
- 15Denali Therapeutics Inc., South San Francisco, CA, USA
- 16Parkinson’s disease & Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED: CB06/05/0018-ISCIII) Barcelona, Spain
- 17Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- 18Institute for Neurodegenerative Disorders, New Haven, CT, USA
- ↵*Correspondence to: Lana Chahine, 3471 Fifth Avenue, Pittsburgh, PA, USA, 15213 E-mail: lchahine2018{at}gmail.com
Posted July 22, 2024.
LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates
